(Total Views: 432)
Posted On: 02/16/2019 7:01:28 PM
Post# of 15624
Re: TryingMyBest93 #14219
not sure if your calculation is correct
+47.7MM common not registered yet and they are going to convert .20 per a share at the current price..
the 7.3MM interest payment already register and they can do what they want with it.
OWC Pharmaceutical Research Corp Raises $5 Million in Preferred Stock Sale to Institutional Investor
https://www.prnewswire.com/news-releases/owc-...19201.html
RAMAT GAN, Israel, May 3, 2018 /PRNewswire/ --
OWC Pharmaceutical Research Corp. (OWCP), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced the closing of the sale of $5 million of convertible preferred stock to an institutional investor. The preferred stock is convertible into OWCP common stock at a price of $0.20 per share. Newbridge Securities Corporation, through LifeTech Capital, acted as exclusive placement agent for the transaction.
+47.7MM common not registered yet and they are going to convert .20 per a share at the current price..
the 7.3MM interest payment already register and they can do what they want with it.
OWC Pharmaceutical Research Corp Raises $5 Million in Preferred Stock Sale to Institutional Investor
https://www.prnewswire.com/news-releases/owc-...19201.html
RAMAT GAN, Israel, May 3, 2018 /PRNewswire/ --
OWC Pharmaceutical Research Corp. (OWCP), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced the closing of the sale of $5 million of convertible preferred stock to an institutional investor. The preferred stock is convertible into OWCP common stock at a price of $0.20 per share. Newbridge Securities Corporation, through LifeTech Capital, acted as exclusive placement agent for the transaction.
(0)
(0)Scroll down for more posts ▼
